...
首页> 外文期刊>Molecular and Cellular Endocrinology >Novel, potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.
【24h】

Novel, potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.

机译:新型有效的1型17β-羟类固醇脱氢酶抑制剂。

获取原文
获取原文并翻译 | 示例

摘要

Many breast tumours are hormone-responsive and rely on estrogens for their sustained growth and development. The enzyme 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) is primarily responsible for the conversion of estrone (E1) into the most potent of the human estrogens 17beta-estradiol (E2). Here we report the syntheses, inhibitory activities and docking studies for a novel series of pyrazole amides which have been discovered with the aim of probing the structure activity relationships (SAR) for such a template and of using this template to mimic the potent inhibitor 1 (Fig. 1). Amides containing an aromatic pyridyl moiety have been found to give the best inhibition, indicating that the pyridyl group interacts beneficially in the active site. This work has shown that extension from this position on the pyrazole template is well tolerated and the optimization of such systems is under investigation.
机译:许多乳腺肿瘤都是激素反应性的,它们依赖雌激素来持续生长和发育。酶17β-羟基类固醇脱氢酶1(17beta-HSD1)主要负责将雌酮(E1)转化为最强效的人类雌激素17β-雌二醇(E2)。在这里,我们报告了一系列新颖的吡唑酰胺的合成,抑制活性和对接研究,这些新发现的吡唑酰胺旨在探索此类模板的结构活性关系(SAR),并使用该模板模拟有效的抑制剂1(图。1)。已经发现含有芳族吡啶基部分的酰胺具有最好的抑制作用,表明吡啶基在活性位点上有利地相互作用。这项工作表明,在吡唑模板上从该位置延伸的耐受性很好,并且正在研究此类系统的优化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号